Rare diseases are often overlooked. As the experts in digestive and metabolic medicine, we focus on the development and distribution of innovative medicines that improve the life of patients suffering from rare diseases.

• Eosinophilic esophagitis (EoE) is a chronic, inflammatory disease of the esophagus leading to swallowing difficulties, pain whilst eating, heartburn and food getting stuck in the esophagus. Patients very often withdraw from social life and lose substantial quality of life.
• Primary biliary cholangitis (PBC) is a chronic autoimmune disease in which the small bile ducts are damaged by inflammation. Without adequate treatment, this inflammation may eventually spread to the tissue of the liver and even cause liver cirrhosis.
• Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that is characterized by inflammatory scarring of the bile ducts progressively blocking them which leads to cirrhosis of the liver and increases the risk of bile duct cancer. Patients are often younger than 40 years old.